PharmaResearch
KOSDAQ:A214450
302.000,00
+ ₩5.000,00 (1,68%)
302.000,00
+₩5.000,00 (1,68%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩8,94k
Earnings Per Share
₩33,66k
Revenue Per Share
71,76%
Gross Margin %
₩3.085,73 B
Market Cap
₩195,87 B
Long-Term Debt
Earnings Per Share
₩8,94k
Revenue Per Share
₩33,66k
Gross Margin %
71,76%
Market Cap
₩3.085,73 B
Long-Term Debt
₩195,87 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2016 2015 2014
EPS Earnings Per Share ₩8,94k ₩7,50k ₩4,11k ₩4,73k ₩3,45k ₩1,85k ₩1,52k ₩1,47k ₩1,25k ₩930,00
Earnings Earnings ₩92,90B ₩76,52B ₩41,06B ₩47,19B ₩33,26B ₩17,38B ₩14,36B ₩13,83B ₩11,47B ₩0,00M
RPS Revenue Per Share ₩33,66k ₩25,57k ₩19,76k ₩15,44k ₩11,27k ₩8,90k ₩6,79k ₩4,89k ₩4,09k N/A
Revenue Revenue ₩349,68B ₩260,84B ₩197,17B ₩154,08B ₩108,75B ₩83,87B ₩64,28B ₩45,95B ₩37,44B ₩0,00M
OCF Operating Cash Flow ₩138,12B ₩64,95B ₩59,40B ₩65,30B ₩32,39B ₩19,43B ₩5,20B ₩8,24B ₩16,02B ₩0,00M
FCF Free Cash Flow ₩101,71B ₩89,55B ₩42,19B ₩44,65B ₩-2,39B ₩9,84B ₩-23,39B ₩6,86B ₩15,67B ₩0,00M
OM Operating Margin 36,00% 35,35% 33,85% 34,07% 30,74% 22,73% 13,54% 30,69% 42,97% 0,00%
GM % Gross Margin % 71,76% 72,89% 72,66% 70,31% 67,03% 59,74% 59,45% 67,11% 68,80% 0,00%
FCFS Free Cash Flow Per Share ₩9,66k ₩5,17k ₩4,18k ₩4,23k ₩-314,65 ₩1,01k ₩-2.058,52 ₩673,96 ₩2,04k ₩0,00
LT Debt Long-Term Debt ₩195,86B ₩970,72M ₩45,36B ₩43,38B ₩10,50B ₩16,50B ₩17,34B N/A ₩5,40B N/A
Sha. Stocks 10,39M 10,2M 9,98M 9,98M 9,65M 9,42M 9,46M 9,4M 9,16M 0M
×